News

Focus Xplore appoints exploration consultants for upcoming programs
Focus Xplore is a strategic energy and critical minerals exploration company with exploration programs in Ontario, Canada. Fladgate has been appointed to complete mapping and sampling activities at ...
Admiral agrees to sell US motor insurance business to JC Flowers
(Alliance News) - Admiral Group PLC on Tuesday said it has agreed to sell its US motor insurance business to private investment firm JC Flowers & Co for an undisclosed fee. The Cardiff, Wales-based ...
BoE rate-setter says US tariffs likely to push down on inflation
[Alliance News] - A Bank of England policymaker has said US trade tariffs are more likely to push down on UK inflation than to push it up, but that there are risks on both sides. Megan Greene told ...
LONDON MARKET MIDDAY: Stocks mixed as UK braces for tariff impact
(Alliance News) - London stocks were mixed at midday on Tuesday, as the pound hit a seven-month high amid US dollar turmoil and UK firms halt plans for investment in anticipation of US tariff upheaval ...
London midday: Sainsbury's, gold miners lift markets but gains limited
London-listed stocks pushed higher by Tuesday lunchtime, though gains were limited with no major economic data or corporate news to steer sentiment following another heavy sell-off on Wall Street the ...
AOTI oxygen therapy enters NHS supply chain framework deal
AOTI Inc on Tuesday announced that its multi-modality topical wound oxygen therapy will be included in the latest NHS supply chain framework agreement. The Oceanside, California-based medical ...
UK firms put the brakes on investment plans post tariffs, survey finds
US President Donald Trump unveiled plans earlier this month to hike tariffs and introduce new levies on all goods being imported. This included a baseline 10% tariff for most countries, including the ...
Arecor Therapeutics sees "significant future growth" as revenue rises
The Cambridgeshire, England-based biopharmaceutical company reported a pretax loss of GBP10.6 million in 2024, widened from GBP8.9 million in 2023. Revenue was GBP5.1 million, up 10% from GBP4.6 ...
Shield Therapeutics inks licencing agreement for iron deficiency drug
The Newcastle, England-based commercial-stage pharmaceutical company said it has entered an exclusive licence agreement for Accrufer with Tokyo-based medical products distributor, Vital Net Inc.
Celebrus shares fall as full-year revenue misses expectations
Shares in Celebrus were down 19% at 170.00 pence in London on Tuesday morning. The Sunbury-on-Thames, England-based data management company expects revenue for the year ended March 31 to be ...
Oracle Power stock falls as placing to fund Australia, Pakistan works
The MoU is to potentially develop, finance, construct, operate and maintain Oracle Energy's green hydrogen project in Thatta, Pakistan. Oracle Power said that the planned production facility, once ...
AIM WINNERS & LOSERS: Celebrus revenue to fall short of guidance
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.